EV/EBITDA
-17.93
0.000.00%
Wed, 12 Feb 2025 00:07:42 GMT
Summary
- As of February 12, 2025, SPRY EV/EBITDA is -17.93, unchanged from the previous trading day.
- Over the past year, SPRY EV/EBITDA has dropped by -7.79 (-76.82%).
- SPRY EV/EBITDA is now -594.96% below its all-time high of -2.58.
Performance
SPRY EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
SPRY EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | 0.0% | 0.0% | 0.0% |
| 1 m1 month | -3.0% | +3.0% | +2.9% |
| 3 m3 months | +34.0% | -34.0% | -33.2% |
| 6 m6 months | +9.8% | +2.6% | +2.6% |
| ytdytd | -7.8% | +7.8% | +7.5% |
| 1 y1 year | -76.8% | +58.5% | +47.8% |
| 5 y5 years | - | - | - |
SPRY EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -3.8% | -23.28 | +23.0% | |
| 3 m | 3-month | -15.39 | -16.5% | -28.24 | +36.5% |
| 6 m | 6-month | -15.39 | -16.5% | -28.24 | +36.5% |
| 1 y | 1-year | -9.10 | -97.0% | -28.24 | +36.5% |
| 3 y | 3-year | -2.58 | -595.0% | -28.24 | +36.5% |
| 5 y | 5-year | -2.58 | -595.0% | -28.24 | +36.5% |
| alltime | all time | -2.58 | -595.0% | -28.24 | +36.5% |
ARS Pharmaceuticals EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -17.93(+7.8%) |
| 2024 | -16.63(+144.6%) |
| Date | Value |
|---|---|
| 2023 | -6.80(-59.6%) |
| 2022 | -16.82 |
FAQ
- What is ARS Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for ARS Pharmaceuticals?
- What is SPRY EV/EBITDA year-to-date change?
- What is ARS Pharmaceuticals EV/EBITDA year-on-year change?
What is ARS Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of SPRY is -17.93
What is the all time high EV/EBITDA for ARS Pharmaceuticals?
ARS Pharmaceuticals all-time high EV/EBITDA is -2.58
What is SPRY EV/EBITDA year-to-date change?
ARS Pharmaceuticals EV/EBITDA has changed by -1.30 (-7.82%) since the beginning of the year
What is ARS Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, SPRY EV/EBITDA has changed by -7.79 (-76.82%)